Creatine raises brain energy levels and slows cognitive decline: study
Creatine supplementation raises brain phosphocreatine levels and slows cognitive decline in early Alzheimer's patients by approximately 30% in controlled trials.
Creatine, a widely used muscle-building supplement, crosses the blood-brain barrier and raises phosphocreatine levels in neurons, supporting ATP regeneration during high metabolic demand. The brain consumes 20% of the body's energy despite comprising only 2% of its mass; neurons lack meaningful energy reserves and rely on continuous ATP supply.
Alzheimer's patients show significantly lower phosphocreatine levels and reduced creatine kinase activity in brain tissue, creating a bioenergetic crisis. The University of Kansas Medical Center's CABA trial found that 20 grams daily for eight weeks improved cognitive function and measurably increased brain phosphocreatine on MRI scans. A 2026 multicenter trial of 240 early Alzheimer's patients taking 5 grams daily for 12 weeks showed a 30% slowing of cognitive decline versus placebo. Beyond neurodegenerative disease, creatine showed cognitive benefits in healthy adults under metabolic stress, improved sleep-deprivation resilience, and emerged as a depression treatment adjunct.
What HN community is saying
Users report noticeable cognitive effects from creatine, particularly under stress or sleep deprivation, though experiences vary widely. A subset experience negative reactions (irritability, brain fog) and attribute these to inadequate hydration, which creatine requires for proper processing.
The kidney safety concern recurs throughout: commenters correctly distinguish creatine supplementation from creatinine elevation (a kidney function marker), noting that creatinine elevation from supplementation does not indicate kidney damage if baseline function is normal. However, one commenter cautions that extra creatinine could mask actual kidney disease warning signs. Several users report dosing at 5 grams daily as safer than the 20-25 gram loading phase mentioned in research, with suggestions to skip loading altogether for long-term use.